N/A N=12 Urodynamic Feasibility Study Utilizing the UroLift® System
Benign Prostatic Hyperplasia
Primary: Qmax Assessed Using Urodynamic Testing (Cystometry) — 14.0 mL/sec
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=630 Value of Urodynamic Evaluation
Urinary Incontinence
Primary: Self-reported Urinary Incontinence, Irritative and Obstructive Symptoms: Reduction of 70%+ in the Urogenital Distress Inventory From Baseline to 12 Mos and "Very Much"…
N/A N=12 Uroflow Measurements in Healthy Volunteers
Healthy
Primary: Voided Volume — 306 mL
N/A N=42 Uro-NIRS Clinical Study
Lower Urinary Tract Symptoms · Overactive Bladder
Primary: Number of Participants Reporting Downward/Flat/Upward Patterns as Assessed by Near Infrared Spectroscopy (NIRS) for BOO Diagnosis — 9; 4; 13; 4 participants
Phase 4 N=42 Validation of a Real-time Urodynamic Measure of Urinary Urgency
Overactive Bladder Syndrome
Primary: Change in Maximal Cystometric Capacity (mL) — 95; 473.50 milliliters (mL) — p=.005
N/A N=38 Modern Urodynamics System Efficacy (MUSE) Study
Urologic Diseases · Urodynamics
Primary: Percentage of Participants With Insertion Success — 32 Participants
N/A N=30 Exploratory Study Investigating Urodynamic Parameters During Catheterisation
Spinal Cord Injuries · Enlarged Prostate With Lower Urinary Tract Symptoms
Primary: Discomfort During Catheter Insertion on a Visual Analogue Scale — 1.2; 1.0; 1.1 score on a scale
N/A N=10 Portable Pves Study
Lower Urinary Tract Symptoms
Primary: Accurate Vesical PRessure — 18.56; 17.45 cm H2O
Phase 4 N=19 A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
Lower Urinary Tract Symptoms
Primary: Bladder Capacity — 363; 402 milliliters
N/A N=20 T-DOC® NXT Clinical Investigation
Incontinence, Urge
Primary: The Number of Patients in Which the T-DOC® NXT Catheters Are Safe in Measuring Urodynamic Pressure in Adults. — 20 Participants
N/A N=61 e۰Sense® Catheter Clinical Investigation
Urodynamics
Primary: Clinician Safety and Effectiveness Rating of eSense Catheters (Per Patient) — 58 Participants
N/A N=90 Lubricant Versus Lidocaine Gel for Pain Control During Urodynamics
Pelvic Floor Disorders
Primary: Pain During the Pelvic Floor Examination — 0.4; 0.9; 1.3; 3.6 units on Wong Baker pain scale
Phase 2 N=22 Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
Stress Urinary Incontinence
Primary: Change From Baseline in Opening Urethral Pressure (OUP) at Day 7 — 49.86; 49.86; 49.86; 47.92 centimeter of water (cmH2O) — p=0.4907
N/A N=80 Lavender Aromatherapy for Anxiety During Urodynamics
Anxiety · Pain
Primary: Anxiety Measured by VAS — 4; 3 cm — p=0.08
N/A N=20 Evaluation of a Novel Electronic Urine Output Monitor (eUOM)
Oliguria · Polyuria
Primary: Urine Output of SOC Device Versus Accuryn — 0; 5 Patients with airlocks
N/A N=60 The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects
Bladder Outlet Obstruction · Lower Urinary Tract Symptoms
Primary: Mean Urine Flow Rate — 12; 13; 16 ml/s — p=0.44
N/A N=5 A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use
Urology
Primary: Usability Factors; Simple, Doable, and is Comparable to the Ruler-based Manometry Method Using a Questionnaire and Patient Diary. — 65 participants
N/A N=69 Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery
Urinary Incontinence
Primary: Number of Participants Who Passed Bladder Trial — 25; 39 participants
Phase 1 N=20 A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
Overactive Bladder
Primary: Change From Baseline in Maximum Cystometric Capacity at 4 Hours Post Dose 7 on Tolterodine 4 mg and Placebo — 1.15; 0.94 Percentage change — p=0.008
N/A N=56 Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters
Urethral Sphincter Activity
Primary: Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG — -18; 10; 11; -15 microvolts — p=>0.05
N/A N=150 The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence
Overactive Bladder · Urinary Incontinence · Urinary Frequency or Urgency Adverse Event
Primary: Day Urinary Frequency — 7.68; 10.95 number of diurnal micturitions per day
N/A N=23 Effect of Urethral Analgesia on Voiding
Urethral Analgesia
Primary: Voiding Efficiency — 87; 90 Percent voiding efficiency
Phase 2 N=80 URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence
Overactive Bladder With Urge Urinary Incontinence
Primary: Change From Baseline at Week 12 in Average Daily Number of Urgency Episodes — -1.13; -2.43; -3.37 Urgency episodes per day — p==0.1722
Phase 4 N=63 Lessons on Urethral Lidocaine in Urodynamics
Urethra Issue · Pelvic Organ Prolapse · Urinary Incontinence
Primary: Sensation as Indicated by the Volume of Water Filled (ml) at the Time of Patient Perception of First Sensation, First Urge to Void, Strong Urge to Void, and Full Bladder…
N/A N=25 Air-charged vs Water-filled Catheters (Bonn)
Urodynamics
Primary: Maximum Vesical Pressure During Valsalva Manoeuvres — 39.31; 39.44 cmH2O
N/A N=173 Comparing Force of Stream to Retrograde Fill Voiding Trial After Vaginal Apex Suspension
Vaginal Apical Prolapse
Primary: Number of Subjects Catheterized Within the Six-week Post-operative Period Following Surgical Repair of Prolapse, Among Those Discharged Without a Urinary Catheter. — 2…
N/A N=18 Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home
Overactive Bladder
Primary: Change in Urge Incontinence Episodes — 3.9 UUI
N/A N=84 Treatment for Acute Postoperative Voiding Dysfunction
Urinary Retention
Primary: Persistent Retention — 29; 21 participants
Phase 1 N=3 Two Devices for Reflex Voiding Following Spinal Cord Injury
Spinal Cord Injury · Urinary Incontinence
Primary: Number of Participants With a Change in Bladder Pressure — 0 participants
Phase 1 N=16 Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter?
Urinary Incontinence, Stress · Fecal Incontinence
Primary: Urethral Opening Pressure (UOP) — 2.90411; -3.623431 cmH2O — p=0.07